Day: June 16, 2021

TORONTO and MONTREAL, June 16, 2021 (GLOBE NEWSWIRE) — Nexus Real Estate Investment Trust (the “REIT”) (TSX: NXR.UN) announced today an acquisition update, the June distribution, and the expected sale of a retail property located in Beamsville, Ontario. Industrial Acquisitions Completed to Date in 2021March 1, 2021: acquired two industrial buildings in Edmonton, Alberta with 108,156 square feet of gross leasable area (GLA) for $14MM. The buildings are fully leased to non-oil and gas tenants. The REIT issued $7.0MM in Class B LP units to the vendor at a price of $8.20 per unit. The purchase price represented an approximately 8% going in capitalization rate. April 1, 2021: completed the $103.5MM acquisition of six industrial properties in London, Ontario with 1,191,184 square feet of GLA, representing a 6% going-in...

WATERTOWN, Mass., June 16, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock at a public offering price of $37.00 per share. All of the shares of common stock in the offering will be offered by C4T. In addition, C4T granted the underwriters a 30-day option to purchase up to 637,500 additional shares of common stock at the public offering price, less the underwriting discount and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by C4T, are expected to be approximately...

BOCA RATON, June 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom”, the “Company”) a social media platform and original content provider for children under the age of 13, today announced the pricing of an underwritten public offering of 2,409,639 units at a public offering price of $4.15 per unit for aggregate gross proceeds of approximately $10.0 million prior to deducting underwriting discounts, commissions, and other offering expenses. Each unit is comprised of one share of common stock and one warrant to purchase one share of common stock. Each warrant is exercisable for one share of common stock at an exercise price of $4.565 per share and will expire five years from issuance. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional...

Houston, TX, June 16, 2021 (GLOBE NEWSWIRE) —   Date:  August 5, 2021Time:  7:00 a.m. Central time or 8:00 a.m. Eastern timeListen via internet:  http://investors.centerpointenergy.com/Click “Investors”, and click the link “CenterPoint Energy, Inc. Second Quarter 2021 Earnings Conference call Webcast”As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Arkansas, Indiana, Louisiana, Minnesota, Mississippi, Ohio, Oklahoma and Texas. As of March 31, 2021, the company owned approximately $36 billion in assets and also owned 53.7 percent of the common units representing...

CALGARY, Alberta, June 16, 2021 (GLOBE NEWSWIRE) — Suncor today advised that the co-owners of the Terra Nova Floating, Production, Storage and Offloading (FPSO) facility and associated Terra Nova Field (“Terra Nova” or “the project”) have reached an agreement in principle to restructure the project ownership and provide short-term funding towards continuing the development of the Asset Life Extension Project, with the intent to move to a sanction decision in the Fall. A subset of owners will increase their ownership of the project for consideration payable from the other owners. Suncor’s ownership will increase to 48% from approximately 38%. The agreement is subject to finalized terms and approval from all Parties, including board of director approval where appropriate, and is contingent upon the previously disclosed royalty and...

Results from ADAPT showed treatment with efgartigimod provided clinically meaningful improvements in strength and quality of life measures in generalized myasthenia gravis (gMG) Efgartigimod is under U.S. Food and Drug Administration (FDA) review with December 17, 2021 Prescription Drug User Fee Act (PDUFA) target action date Breda, the Netherlands —Jun. 16, 2021— argenx (Euronext & Nasdaq: ARGX), today announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living with generalized myasthenia gravis (gMG). Efgartigimod is currently under review with the U.S. Food and Drug Administration (FDA) for the treatment of gMG with a Prescription Drug User Fee Act (PDUFA) target action date of December 17, 2021, and if approved, would...

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF) (“EMN” or the “Company“) today announced that it will begin implementation of a CEO succession plan. A search will now begin for a new Chief Executive Officer to carry the Company through its next stage of development, as it transitions from a development company to an operating company. Marco Romero, the founder of the Company and its current CEO, will remain in the CEO position until a successor is identified and appointed. Marco Romero said, “I have been looking for the right opportunity to make way for a new CEO for some time and have been working closely with the Board to set the stage for a transition. This current phase, where we are busy completing our...